RecruitingNCT07559903

ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)

Sponsor

Emory University

Enrollment

5,000 participants

Start Date

Jun 1, 2026

Study Type

OBSERVATIONAL

Conditions

Coronary Artery Disease

Summary

The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with coronary artery disease. The study is currently recruiting participants at 19 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(19)

Banner University Medical Center

Phoenix, Arizona, United States

Holy Cross Health Fort Lauderdale

Fort Lauderdale, Florida, United States

Emory University Hospital Midtown

Atlanta, Georgia, United States

Emory University Hospital

Atlanta, Georgia, United States

Emory Saint Joseph's Hospital

Atlanta, Georgia, United States

Emory Johns Creek Hospital

Johns Creek, Georgia, United States

Tufts Medical Center

Boston, Massachusetts, United States

Brigham and Women's Hospital

Boston, Massachusetts, United States

Allina Health Minneapolis Heart Institute

Minneapolis, Minnesota, United States

The Mount Sinai Hospital

New York, New York, United States

New York-Presbyterian/Weill Cornell Medical Center

New York, New York, United States

Montefiore Medical Center

New York, New York, United States

St. Francis Hospital & Heart Center

Roslyn, New York, United States

Sanger Heart & Vascular Institute

Charlotte, North Carolina, United States

Duke University Hospital

Durham, North Carolina, United States

University Hospitals Cleveland Medical Center

Cleveland, Ohio, United States

Vanderbilt University Medical Center

Nashville, Tennessee, United States

Universitatsklinikum des Saarlandes

Homberg (Efze), Germany

University Clinical Centre of Serbia

Belgrade, Serbia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07559903

Related Trials

Digital Long-term Follow-up of Patients With Coronary Artery Disease

NCT077203492 locations

Gangwon PCI Prospective Registry

NCT020381273 locations

Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions

NCT0719069018 locations

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

NCT072582902 locations

Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

NCT0677963023 locations